Figure 5From: YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma Association of between combination of sorafenib and YC-1 and STAT3 cascade. Back to article page